UroGen Pharma (URGN) Assets Growth (3y) (2019 - 2026)
UroGen Pharma (URGN) Assets Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | UroGen Pharma | 2.05 Bn | 1.91 Bn | 46.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.96% |
| Dec 31, 2025 | 13.91% |
| Sep 30, 2025 | 12.93% |
| Jun 30, 2025 | 12.61% |
| Mar 31, 2025 | 14.32% |
| Dec 31, 2024 | 33.63% |
| Sep 30, 2024 | 30.91% |
| Jun 30, 2024 | 22.38% |
| Mar 31, 2024 | 27.22% |
| Dec 31, 2023 | 13.48% |
| Sep 30, 2023 | 11.45% |
| Jun 30, 2023 | -16.03% |
| Mar 31, 2023 | -12.21% |
| Dec 31, 2022 | -12.49% |
| Sep 30, 2022 | -17.25% |
| Jun 30, 2022 | -15.07% |
| Mar 31, 2022 | -13.05% |
| Dec 31, 2021 | 4.96% |
| Dec 31, 2020 | 17.32% |
| Dec 31, 2019 | 106.28% |